March 4, 2021
Immunocompromised Hosts & Transplant ID
Debate: Viral specific T-cell immunity can be used to determine immune competence following transplantation
Moderator: Hayley Gans, MD, Stanford University
Debate Team: Amina Ahmed, MD, Levine Children’s Hospital at Carolinas Medical Center and Inci Yildirim, MD, PhD, Yale University School of Medicine
Pro Debater: Lars Pape, MD, University Hospital of Essen
Con Debater: Hamid Bassiri, MD, PhD, Children’s Hospital of Philadelphia
Challenging Cases in Hematopoietic Stem Cell Transplant and Oncology Patients
Gabriela Maron, MD, St. Jude Children’s Research Hospital
Inci Yildirim, MD, PhD, MSc, Yale University School of Medicine
Challenging Cases in Solid Organ Transplant Recipients
Flor Munoz-Rivas, MD, Texas Children’s Hospital
Benjamin Hanisch, MD, Children’s National Medical Center
Challenging Cases in Other Immunocompromised Hosts
William Muller, MD, PhD, Lurie Children’s Hospital of Chicago
Amina Ahmed, MD, Levine Children’s Hospital at Carolinas Medical Center
Abstract Presentations
Clinical Features and Management of Pediatric Patients Presenting with New Onset Acute Leukemia and Concomitant COVID-19
Pratik Atul Patel, MD, Emory University School of Medicine
Rifaximin for Prevention of Bloodstream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation (HCT)
Mehgan Teherani, MD, Emory University School of Medicine
The Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients
Alvaro Galvis, MD, Children’s Hospital of Orange County
Respiratory and Intestinal Epithelial Cells Exhibit Differential Susceptibility and Innate Immune Responses to Contemporary EV-D68 Isolates
Megan Freeman, MD, PhD, UPMC Children’s Hospital of Pittsburgh
Disease and Immunoprophylaxis Model of Human Nose Organoids to Study SARS-CoV-2 and RSV Infection
Anubama Rajan, PhD, Baylor College of Medicine